No photo of David M Ferguson
Contact Expert

View Scopus Profile

David M Ferguson

1985 …2023

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Overcoming Pyrazinamide Resistance with Pyrazinoate-Cephalosporin Conjugates

Aldrich, C., Baughn, A. & Ferguson, D. M.

NIH Nat'l Inst of Allergy & Infect Dis

1/25/20 → 12/31/21

Project: Research project

    • Targeting Biotin Metabolism in Mycobacterium Tuberculosis

    Aldrich, C. & Ferguson, D. M.

    NIH Nat'l Inst of Allergy & Infect Dis

    1/15/19 → 12/31/23

    Project: Research project

    • Design and Synthesis of TLR7, TLR8, and NLRP3 Immunostimulatory Agents

    Ferguson, D. M.

    Seattle Genetics, Inc.

    12/18/18 → 12/31/20

    Project: Research project

    Siderophore Inhibitors for Tuberculosis that Block Mycob

    Aldrich, C. & Ferguson, D. M.

    NIH Nat'l Inst of Allergy & Infect Dis

    4/25/18 → 3/31/23

    Project: Research project

    • MIKI Meeting in Miniature

    Ferguson, D. M.

    Genentech Inc.

    3/1/17 → 6/30/17

    Project: Research project

    Research Output

    A Cinchona Alkaloid Antibiotic That Appears to Target ATP Synthase in Streptococcus pneumoniae

    Wang, X., Zeng, Y., Sheng, L., Larson, P., Liu, X., Zou, X., Wang, S., Guo, K., Ma, C., Zhang, G., Cui, H., Ferguson, D. M., Li, Y., Zhang, J. & Aldrich, C. C., Mar 14 2019, In : Journal of medicinal chemistry. 62, 5, p. 2305-2332 28 p.

    Research output: Contribution to journal › Article

    • 2 Scopus citations

    Combination of Sunitinib and PD-L1 Blockade Enhances Anticancer Efficacy of TLR7/8 Agonist-Based Nanovaccine

    Kim, H., Khanna, V., Kucaba, T. A., Zhang, W., Ferguson, D. M., Griffith, T. S. & Panyam, J., Mar 4 2019, In : Molecular pharmaceutics. 16, 3, p. 1200-1210 11 p.

    Research output: Contribution to journal › Article

    • 1 Scopus citations

    Investigation of (S)-(-)-acidomycin: A selective antimycobacterial natural product that inhibits biotin synthase

    Bockman, M. R., Engelhart, C. A., Cramer, J. D., Howe, M. D., Mishra, N. K., Zimmerman, M., Larson, P., Alvarez-Cabrera, N., Park, S. W., Boshoff, H. I. M., Bean, J. M., Young, V. G., Ferguson, D. M., Dartois, V., Jarrett, J. T., Schnappinger, D. & Aldrich, C., Apr 12 2019, In : ACS Infectious Diseases. 5, 4, p. 598-617 20 p.

    Research output: Contribution to journal › Article

    • 1 Scopus citations

    Acidic pH-responsive polymer nanoparticles as a TLR7/8 agonist delivery platform for cancer immunotherapy

    Kim, H., Sehgal, D., Kucaba, T. A., Ferguson, D. M., Griffith, T. S. & Panyam, J., Nov 28 2018, In : Nanoscale. 10, 44, p. 20851-20862 12 p.

    Research output: Contribution to journal › Article

    • 11 Scopus citations

    Avoiding Antibiotic Inactivation in Mycobacterium tuberculosis by Rv3406 through Strategic Nucleoside Modification

    Bockman, M. R., Engelhart, C. A., Dawadi, S., Larson, P., Tiwari, D., Ferguson, D. M., Schnappinger, D. & Aldrich, C. C., Jul 13 2018, In : ACS Infectious Diseases. 4, 7, p. 1102-1113 12 p.

    Research output: Contribution to journal › Article

    • 7 Scopus citations